Picture of Thc Therapeutics logo

THCT Thc Therapeutics Income Statement

0.000.00%
us flag iconLast trade - 00:00
IndustrialsHighly SpeculativeMicro CapSucker Stock

Annual income statement for Thc Therapeutics, fiscal year end - July 31st, USD millions except per share, conversion factor applied.

2019
July 31st
R2020
July 31st
2021
July 31st
2022
July 31st
2023
July 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue00000
Cost of Revenue
Gross Profit00000
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses19.11.560.941.750.492
Operating Profit-19.1-1.56-0.94-1.75-0.492
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-23.3-1.93-1.89-1.52-0.387
Net Income After Taxes-23.3-1.93-1.89-1.52-0.387
Net Income Before Extraordinary Items
Net Income-23.3-1.93-1.89-1.52-0.387
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-23.3-1.93-1.89-1.52-0.387
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-2.13-0.107-0.08-0.046-0.012